Total Payments
$27,321
2024 Payments
$224.88
Companies
18
Transactions
212
Medicare Patients
9,986
Medicare Billing
$556,977
Payment Breakdown by Category
Other$23,290 (85.2%)
Food & Beverage$2,984 (10.9%)
Travel$1,046 (3.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,290 | 21 | 85.2% |
| Food and Beverage | $2,984 | 187 | 10.9% |
| Travel and Lodging | $1,046 | 4 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $15,394 | 20 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $8,217 | 13 | $0 (2022) |
| Abbott Laboratories | $1,008 | 13 | $0 (2024) |
| Lilly USA, LLC | $990.00 | 2 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $398.24 | 38 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $366.91 | 80 | $0 (2018) |
| Edwards Lifesciences Corporation | $174.35 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $132.51 | 10 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $124.23 | 7 | $0 (2023) |
| PFIZER INC. | $122.31 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $224.88 | 2 | Edwards Lifesciences Corporation ($174.35) |
| 2023 | $75.37 | 2 | Intuitive Surgical, Inc. ($60.00) |
| 2022 | $11,317 | 14 | Boehringer Ingelheim Pharmaceuticals, Inc. ($8,152) |
| 2021 | $7,300 | 12 | AstraZeneca Pharmaceuticals LP ($7,080) |
| 2020 | $6,324 | 9 | AstraZeneca Pharmaceuticals LP ($6,163) |
| 2019 | $278.97 | 11 | Abbott Laboratories ($165.62) |
| 2018 | $1,267 | 88 | Abbott Laboratories ($548.68) |
| 2017 | $533.61 | 74 | Novartis Pharmaceuticals Corporation ($213.22) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/19/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $50.53 | General |
| Category: Heart Failure | ||||||
| 03/06/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $174.35 | General |
| Category: Transcatheter Heart Valves | ||||||
| 04/11/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.37 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/24/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: SURGERY | ||||||
| 09/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: DIABETES | ||||||
| 09/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: DIABETES | ||||||
| 09/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $781.80 | General |
| Category: DIABETES | ||||||
| 09/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $120.47 | General |
| Category: DIABETES | ||||||
| 08/30/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: DIABETES | ||||||
| 08/19/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: DIABETES | ||||||
| 08/11/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: DIABETES | ||||||
| 07/17/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/12/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $440.00 | General |
| Category: Diabetes | ||||||
| 07/07/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: DIABETES | ||||||
| 05/27/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Diabetes | ||||||
| 05/05/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/28/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $51.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/20/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Heart Failure | ||||||
| 10/09/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $143.95 | General |
| Category: Heart Failure | ||||||
| 08/05/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $76.33 | General |
| Category: Heart Failure | ||||||
| 07/12/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/06/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/30/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $68.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/17/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/08/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,129 | 2,461 | $439,086 | $125,299 |
| 2022 | 23 | 2,561 | 2,969 | $533,163 | $146,448 |
| 2021 | 22 | 2,612 | 3,202 | $539,941 | $150,698 |
| 2020 | 27 | 2,684 | 3,343 | $530,545 | $134,532 |
Total Patients
9,986
Total Services
11,975
Medicare Billing
$556,977
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 542 | 778 | $138,484 | $68,783 | 49.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 240 | 241 | $71,095 | $12,523 | 17.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $20,286 | $8,082 | 39.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 98 | 98 | $43,904 | $5,375 | 12.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 55 | 56 | $17,248 | $5,366 | 31.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 67 | $11,055 | $4,046 | 36.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 44 | $10,296 | $3,719 | 36.1% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 71 | 71 | $10,714 | $3,255 | 30.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 307 | 351 | $38,827 | $2,080 | 5.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 206 | 207 | $16,974 | $2,051 | 12.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $3,765 | $1,967 | 52.2% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 24 | 24 | $9,168 | $1,966 | 21.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 135 | 136 | $14,960 | $1,398 | 9.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 17 | 22 | $3,916 | $1,378 | 35.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 56 | 59 | $8,260 | $1,071 | 13.0% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 22 | 23 | $1,587 | $620.77 | 39.1% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 29 | 29 | $3,944 | $383.40 | 9.7% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2023 | 13 | 14 | $826.00 | $368.20 | 44.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 46 | 50 | $3,250 | $280.80 | 8.6% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 20 | 20 | $2,820 | $273.60 | 9.7% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 37 | 39 | $3,003 | $201.65 | 6.7% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 47 | 48 | $4,704 | $110.40 | 2.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 558 | 803 | $142,934 | $69,444 | 48.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 313 | 314 | $92,630 | $15,843 | 17.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 90 | 90 | $26,460 | $10,825 | 40.9% |
About Dr. Javier Jurado, M.D
Dr. Javier Jurado, M.D is a Cardiovascular Disease healthcare provider based in Evansville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1104099142.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Javier Jurado, M.D has received a total of $27,321 in payments from pharmaceutical and medical device companies, with $224.88 received in 2024. These payments were reported across 212 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($23,290).
As a Medicare-enrolled provider, Jurado has provided services to 9,986 Medicare beneficiaries, totaling 11,975 services with total Medicare billing of $556,977. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Evansville, IN
- Active Since 04/10/2008
- Last Updated 07/06/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1104099142
Products in Payments
- FARXIGA (Drug) $15,394
- JARDIANCE (Drug) $9,142
- HeartMate (Device) $464.77
- ENTRESTO (Drug) $398.24
- XARELTO (Drug) $366.91
- CardioMEMS HF System (Device) $224.51
- SAPIEN 3 Ultra RESILIA (Device) $174.35
- Circulatory Support (Device) $148.01
- LifeVest (Device) $124.23
- VYNDAQEL (Drug) $111.53
- HeartMate 3 Left Ventricular Dev (Device) $97.29
- LEXISCAN (Drug) $89.55
- PRADAXA (Drug) $64.88
- Da Vinci Surgical System (Device) $60.00
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $50.53
- Lexiscan (Drug) $42.96
- ZIO Patch (Device) $42.18
- MULTAQ (Drug) $40.41
- HeartWare HVAD (Device) $30.74
- Corlanor (Drug) $30.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Evansville
Dr. Jarrod Frizzell, Md, MD
Cardiovascular Disease — Payments: $67,717
Cardiovascular Disease $67,717
Ashwani Bedi, M.d, M.D
Cardiovascular Disease — Payments: $12,742
Cardiovascular Disease $12,742
Edward Moore, Md, MD
Cardiovascular Disease — Payments: $8,036
Cardiovascular Disease $8,036
Dr. Phillip Behrens, Md, MD
Cardiovascular Disease — Payments: $6,113
Cardiovascular Disease $6,113
Gurtej Singh, Md, MD
Cardiovascular Disease — Payments: $4,943
Cardiovascular Disease $4,943
Naveen Devabhaktuni, M.d, M.D
Cardiovascular Disease — Payments: $3,861
Cardiovascular Disease $3,861